154 related articles for article (PubMed ID: 8372197)
21. Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET.
Delbeke D; Meyerowitz C; Lapidus RL; Maciunas RJ; Jennings MT; Moots PL; Kessler RM
Radiology; 1995 Apr; 195(1):47-52. PubMed ID: 7892494
[TBL] [Abstract][Full Text] [Related]
22. [Value of contrast enhancement with Gd-DTPA in MRI of brain tumors. A comparison with X-ray CT].
Tsuji T; Kishikawa T; Ikezaki K; Fujii K; Matsumoto S; Koga T
Fukuoka Igaku Zasshi; 1987 Dec; 78(12):578-97. PubMed ID: 3447928
[No Abstract] [Full Text] [Related]
23. Differentiation between Solitary Cerebral Metastasis and Astrocytoma on the Basis of Subventricular Zone Involvement on Magnetic Resonance Imaging.
Wang R; Ma J; Niu G; Zheng J; Liu Z; Du Y; Yu B; Yang J
PLoS One; 2015; 10(7):e0133480. PubMed ID: 26197398
[TBL] [Abstract][Full Text] [Related]
24. Differential imaging characteristics and dissemination potential of pilomyxoid astrocytomas versus pilocytic astrocytomas.
Alkonyi B; Nowak J; Gnekow AK; Pietsch T; Warmuth-Metz M
Neuroradiology; 2015 Jun; 57(6):625-38. PubMed ID: 25666233
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of pleomorphic xanthoastrocytoma by use of positron emission tomography with.
Tsuyuguchi N; Matsuoka Y; Sunada I; Matsusaka Y; Haque M
AJNR Am J Neuroradiol; 2001 Feb; 22(2):311-3. PubMed ID: 11156775
[TBL] [Abstract][Full Text] [Related]
26. Effect of radiation on blood volume in low-grade astrocytomas and normal brain tissue: quantification with dynamic susceptibility contrast MR imaging.
Wenz F; Rempp K; Hess T; Debus J; Brix G; Engenhart R; Knopp MV; van Kaick G; Wannenmacher M
AJR Am J Roentgenol; 1996 Jan; 166(1):187-93. PubMed ID: 8571873
[TBL] [Abstract][Full Text] [Related]
27. Quantification of inflammation in the wrist with gadolinium-enhanced MR imaging and PET with 2-[F-18]-fluoro-2-deoxy-D-glucose.
Palmer WE; Rosenthal DI; Schoenberg OI; Fischman AJ; Simon LS; Rubin RH; Polisson RP
Radiology; 1995 Sep; 196(3):647-55. PubMed ID: 7644624
[TBL] [Abstract][Full Text] [Related]
28. MRI of temporal lobe pleomorphic xanthoastrocytoma.
Rippe DJ; Boyko OB; Radi M; Worth R; Fuller GN
J Comput Assist Tomogr; 1992; 16(6):856-9. PubMed ID: 1385498
[TBL] [Abstract][Full Text] [Related]
29. Pilocytic astrocytomas: well-demarcated magnetic resonance appearance despite frequent infiltration histologically.
Coakley KJ; Huston J; Scheithauer BW; Forbes G; Kelly PJ
Mayo Clin Proc; 1995 Aug; 70(8):747-51. PubMed ID: 7630212
[TBL] [Abstract][Full Text] [Related]
30. Unusual MR and CT appearance of an epidermoid tumor.
Gualdi GF; Di Biasi C; Trasimeni G; Pingi A; Vignati A; Maira G
AJNR Am J Neuroradiol; 1991; 12(4):771-2. PubMed ID: 1882763
[No Abstract] [Full Text] [Related]
31. Metabolic imaging of human extremity musculoskeletal tumors by PET.
Kern KA; Brunetti A; Norton JA; Chang AE; Malawer M; Lack E; Finn RD; Rosenberg SA; Larson SM
J Nucl Med; 1988 Feb; 29(2):181-6. PubMed ID: 2831318
[TBL] [Abstract][Full Text] [Related]
32. Correlation of glucose consumption and tumor cell density in astrocytomas. A stereotactic PET study.
Herholz K; Pietrzyk U; Voges J; Schröder R; Halber M; Treuer H; Sturm V; Heiss WD
J Neurosurg; 1993 Dec; 79(6):853-8. PubMed ID: 8246053
[TBL] [Abstract][Full Text] [Related]
33. PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome.
Valk PE; Budinger TF; Levin VA; Silver P; Gutin PH; Doyle WK
J Neurosurg; 1988 Dec; 69(6):830-8. PubMed ID: 2848111
[TBL] [Abstract][Full Text] [Related]
34. Delineation of gliomas with magnetic resonance imaging using Gd-DTPA in comparison with computed tomography and positron emission tomography.
Tovi M; Lilja A; Bergström M; Ericsson A; Bergström K; Hartman M
Acta Radiol; 1990 Sep; 31(5):417-29. PubMed ID: 2261284
[TBL] [Abstract][Full Text] [Related]
35. In vivo metabolism of childhood posterior fossa tumors and primitive neuroectodermal tumors before and after treatment.
Holthoff VA; Herholz K; Berthold F; Widemann B; Schröder R; Neubauer I; Heiss WD
Cancer; 1993 Aug; 72(4):1394-403. PubMed ID: 8339230
[TBL] [Abstract][Full Text] [Related]
36. Contrast enhancement of cystic portions in brain tumors on delayed image of gadolinium-DTPA-enhanced MR imaging.
Suzuki M; Takashima T; Kadoya M; Konishi H; Kawamori Y; Ueda F; Tamura S; Yamamoto T; Kawahara K; Yamashima T
Radiat Med; 1991; 9(1):14-8. PubMed ID: 1852900
[TBL] [Abstract][Full Text] [Related]
37. Comparison of MR spectroscopy and MR imaging with contrast agent in children with cerebral astrocytomas.
Dezortová M; Hájek M; Cáp F; Babis M; Tichý M; Vymazal J
Childs Nerv Syst; 1999 Aug; 15(8):408-12. PubMed ID: 10447614
[TBL] [Abstract][Full Text] [Related]
38. [A case of pilocytic astrocytoma in an adult].
Murahashi T; Sato K; Ito T; Ozaki Y; Sugio H; Nakamura H; Tanaka S
No Shinkei Geka; 2012 Sep; 40(9):793-7. PubMed ID: 22915701
[TBL] [Abstract][Full Text] [Related]
39. Use of [18F]fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors.
Janus TJ; Kim EE; Tilbury R; Bruner JM; Yung WK
Ann Neurol; 1993 May; 33(5):540-8. PubMed ID: 8498831
[TBL] [Abstract][Full Text] [Related]
40. Perfusion-sensitive MRI of pilocytic astrocytomas: initial results.
Grand SD; Kremer S; Tropres IM; Hoffmann DM; Chabardes SJ; Lefournier V; Berger FR; Pasteris C; Krainik A; Pasquier BM; Peoch M; Le Bas JF
Neuroradiology; 2007 Jul; 49(7):545-50. PubMed ID: 17530237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
